Pharmaceutical companies can extend the protection period of an authorised medicinal product by up to a further five years after the expiry of the patent with a supplementary protection certificate (SPC). In addition, they can extend protection for a further six months (where necessary) if they have carried out paediatric studies for a medicinal product (known as a paediatric extension).
The six-month extension can be obtained in one of two ways:
- either by extending an already granted conventional SPC, or if no conventional SPC exists...
- with a paediatric SPC, which is directly linked to the term of the patent.
Requirements for a requesting an extension:
- For a medicinal product to obtain marketing authorisation, clinical trials must be carried out on children in accordance with a paediatric investigation plan (PIP).
- The results of this PIP must be published in the product information of the medicinal product in question.
- The application for the marketing authorisation in Switzerland for a paediatric medicinal product must not be made later than six months after the application for marketing authorisation in the European Economic Area.
- Background information on the introduction of paediatric extensions
- Swissmedic, Swiss Agency for Therapeutic Products – medicines for children
- Patent Examination Guidelines in German
- Patent Examination Guidelines in French
- Application for the grant of a paediatric supplementary protection certificate (in German)
- Application for the grant of a paediatric supplementary protection certificate (in French)
- Application for the grant of a paediatric supplementary protection certificate (in Italian)
- Application for the extension of a supplementary protection certificate for medicinal products (in German)
- Application for the extension of a supplementary protection certificate for medicinal products (in French)
- Application for the extension of a supplementary protection certificate for medicinal products (in Italian)
The IPI’s IP Management Award goes to Pettastic!
A strategy for success – how a Swiss start-up protects its inventions
Federal Council adopts strategic objectives for Swiss Federal Institute of Intellectual Property
Termination of the Agreement between Switzerland and Germany on Reciprocal Protection for Patents, Designs and Trade Marks
Conference on intellectual property law – industrial data sharing, 7 June 2022
EPO/IPI - invitation to a free public online seminar on patenting topics in green tech
How SMEs protect their primary raw material – know-how
Swiss Innovation Forum 2020 to be held as an online festival